To include your compound in the COVID-19 Resource Center, submit it here.

Alector, AbbVie in Alzheimer's deal

Alector LLC (San Francisco, Calif.) and AbbVie Inc. (NYSE:ABBV) partnered to discover and develop immuno-neurology therapies

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE